Table 2. Study 2: Primate Characteristics and Treatment.
animal no. | treatment | wt (kg) | dose (ivp/kg) | route of admin | age (years) |
---|---|---|---|---|---|
0810091 | KPBS | 8.7 | IM | 6 | |
0805201 | KPBS | 6.8 | IM | 6 | |
0802197 | Ad-CAGoptZGP | 6.2 | 1.6 × 109 | IN/IT | 6 |
0809077 | Ad-CAGoptZGP | 6.5 | 1.5 × 109 | IN/IT | 6 |
0810003 | Ad-CAGoptZGP | 5.8 | 1.7 × 109 | IN/IT | 6 |
0805257 | Ad-CAGoptZGP | 4.9 | 2.0 × 1010 | SL | 6 |
0804317 | Ad-CAGoptZGP | 4.8 | 2.0 × 1010 | SL | 6 |
0808233 | Ad-CAGoptZGP | 4.8 | 2.0 × 1010 | SL | 6 |
0809227 | Ad5MUT | 5.5 | 1.8 × 1010 | IM | 6 |
Ad-CAGoptZGP | 1.8 × 1010 | SL | |||
0804819 | Ad5MUT | 5.2 | 1.9 × 1010 | IM | 6 |
Ad-CAGoptZGP | 1.9 × 1010 | SL | |||
0807243 | Ad5MUT | 4.9 | 2 × 1010 | IM | 6 |
Ad-CAGoptZGP | 2 × 1010 | SL |